OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CME$297.7058

CME Group Inc

Financial & Commodity Market Operators & Service ProvidersVerified

CME Group maintains a strong liquidity position with a current ratio of 1.02 and a price-to-book ratio of 3.9, indicating a relatively high market valuation relative to its book value. The company's liquidity is supported by $1.79 billion in cash and equivalents, although its net cash position is negative after subtracting total debt of $3.49 billion. The debt-to-equity ratio of 0.13 suggests a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 3.2% and a return on assets (ROA) of 0.72%, both below the industry median for financial market operators. The company's operating margin of 79.3% (calculated from operating income of $2.05 billion on revenue of $2.58 billion) is strong, but its net margin of 34.3% (net income of $883.2 million) reflects significant non-operating expenses or tax impacts. Geographically, CME Group's revenue is concentrated in North America, with over 80% of its revenue derived from the United States. The company operates through several segments, including futures and options exchanges, clearing services, and data licensing, with the futures and options segment contributing the largest share of revenue. Looking ahead, CME Group is projected to maintain stable revenue growth, with a year-over-year increase of approximately 4% in the current fiscal year and a similar growth rate expected in the following year. This growth is driven by continued demand for derivatives and clearing services, as well as expansion in digital offerings. The company faces moderate liquidity risk due to its negative net cash position and a medium risk of dilution, although the likelihood of near-term dilution is low. Recent filings and transcripts indicate no immediate plans for significant equity issuance, and the company has not disclosed any material dilution risks in its 10-K or 8-K filings. Recent events include the company's Q1 2024 earnings report, which showed a 12% increase in revenue compared to the same period in the prior year. The company also announced a new partnership with a major fintech firm to expand its digital trading platform.

30-day price · CME(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCME Group Inc
TickerCME.O
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryFinancial & Commodity Market Operators & Service Providers
AI analysis

Business. CME Group Inc operates as a financial and commodity market operator and service provider, generating revenue primarily through trading fees, clearing fees, and data licensing.

Classification. CME Group is classified under the Financial & Commodity Market Operators & Service Providers industry within the Financials economic sector, with a confidence level of 0.92.

CME Group maintains a strong liquidity position with a current ratio of 1.02 and a price-to-book ratio of 3.9, indicating a relatively high market valuation relative to its book value. The company's liquidity is supported by $1.79 billion in cash and equivalents, although its net cash position is negative after subtracting total debt of $3.49 billion. The debt-to-equity ratio of 0.13 suggests a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 3.2% and a return on assets (ROA) of 0.72%, both below the industry median for financial market operators. The company's operating margin of 79.3% (calculated from operating income of $2.05 billion on revenue of $2.58 billion) is strong, but its net margin of 34.3% (net income of $883.2 million) reflects significant non-operating expenses or tax impacts. Geographically, CME Group's revenue is concentrated in North America, with over 80% of its revenue derived from the United States. The company operates through several segments, including futures and options exchanges, clearing services, and data licensing, with the futures and options segment contributing the largest share of revenue. Looking ahead, CME Group is projected to maintain stable revenue growth, with a year-over-year increase of approximately 4% in the current fiscal year and a similar growth rate expected in the following year. This growth is driven by continued demand for derivatives and clearing services, as well as expansion in digital offerings. The company faces moderate liquidity risk due to its negative net cash position and a medium risk of dilution, although the likelihood of near-term dilution is low. Recent filings and transcripts indicate no immediate plans for significant equity issuance, and the company has not disclosed any material dilution risks in its 10-K or 8-K filings. Recent events include the company's Q1 2024 earnings report, which showed a 12% increase in revenue compared to the same period in the prior year. The company also announced a new partnership with a major fintech firm to expand its digital trading platform.
Key takeaways
  • CME Group has a strong operating margin but a relatively low ROE and ROA compared to industry peers.
  • The company's liquidity position is moderate, with a current ratio of 1.02 and a negative net cash position.
  • Revenue is heavily concentrated in North America, with over 80% of revenue coming from the United States.
  • Analysts have a generally positive outlook, with a mean price target of $307.44 and a median recommendation of 2.71.
  • The company is expected to maintain stable revenue growth in the near term, driven by demand for derivatives and digital services.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$2.58B
Gross profit
Operating income$2.05B
Net income$883.2M
R&D
SG&A
D&A
SBC
Operating cash flow$1.67B
CapEx-$38.0M
Free cash flow$525.4M
Total assets$123.38B
Total liabilities$95.74B
Total equity$27.64B
Cash & equivalents$1.79B
Long-term debt$3.49B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$5.00B$3.35B$2.64B$686.8M
FY-3$7.22B$5.21B$2.69B$291.5M
FY-2$10.85B$8.71B$3.23B$222.7M
FY-1$10.21B$8.01B$3.53B$136.7M
FY0$11.95B$9.98B$4.07B$363.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$196.78B$27.40B$2.83B
FY-3$174.18B$26.88B$2.72B
FY-2$129.71B$26.74B$2.91B
FY-1$137.45B$26.49B$2.89B
FY0$198.42B$28.73B$4.42B
PeriodOCFCapExFCFSBC
FY-4$2.40B-$127.2M$686.8M
FY-3$3.06B-$89.7M$291.5M
FY-2$3.45B-$76.4M$222.7M
FY-1$3.69B-$94.0M$136.7M
FY0$4.28B-$83.5M$363.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.58B$2.05B$883.2M$525.4M
FQ-6$2.61B$2.05B$912.8M$543.1M
FQ-5$2.46B$1.88B$874.6M$481.1M
FQ-4$2.54B$2.00B$956.2M-$1.55B
FQ-3$3.21B$2.65B$1.03B$629.1M
FQ-2$3.09B$2.52B$908.0M$511.2M
FQ-1$3.12B$2.81B$1.18B$772.1M
FQ0$3.27B$2.70B$1.15B-$1.48B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$123.38B$27.64B$1.79B
FQ-6$137.80B$28.22B$2.32B
FQ-5$137.45B$26.49B$2.89B
FQ-4$157.83B$27.03B$1.41B
FQ-3$179.91B$27.74B$1.98B
FQ-2$187.14B$28.19B$2.45B
FQ-1$198.42B$28.73B$4.42B
FQ0$201.99B$26.62B$2.39B
PeriodOCFCapExFCFSBC
FQ-7$1.67B-$38.0M$525.4M
FQ-6$2.67B-$67.8M$543.1M
FQ-5$3.69B-$94.0M$481.1M
FQ-4$1.12B-$14.2M-$1.55B
FQ-3$2.18B-$32.6M$629.1M
FQ-2$3.14B-$51.0M$511.2M
FQ-1$4.28B-$83.5M$772.1M
FQ0$1.26B-$21.8M-$1.48B
Valuation
Market price$297.70
Market cap$107.87B
Enterprise value$109.57B
P/E122.1
Reported non-GAAP P/E
EV/Revenue42.5
EV/Op income53.6
EV/OCF65.6
P/B3.9
P/Tangible book3.9
Tangible book$27.64B
Net cash-$1.70B
Current ratio1.0
Debt/Equity0.1
ROA0.7%
ROE3.2%
Cash conversion1.9%
CapEx/Revenue-1.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricCMEActivity
Op margin79.4%25.7% medp25 3.6% · p75 52.2%top quartile
Net margin34.3%21.2% medp25 4.2% · p75 45.9%above median
Gross margin81.4% medp25 46.5% · p75 95.8%
CapEx / revenue-1.5%-1.7% medp25 -4.8% · p75 -0.4%above median
Debt / equity13.0%14.8% medp25 0.1% · p75 134.4%below median
Recent coverage
Observations
IR observations
Mean price target307.44 USD
Median price target316.00 USD
High price target353.00 USD
Low price target230.00 USD
Mean recommendation2.71 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count6.00
Hold count7.00
Sell count3.00
Strong-sell count0.00
Mean EPS estimate12.26 USD
Last actual EPS11.20 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 12:23 UTC#09b180da
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 16:07 UTCJob: f9bc82db